GlaxoSmithKline (Licensor)Renaissance Acquisition Holdings (Licensee)
GlaxoSmithKline granted Renaissance rights to market six approved dermatology drugs and three formulations of Zovirax acyclovir in the U.S.
GlaxoSmithKline (Seller)Valeant Pharmaceuticals (Buyer)
Valeant's Biovail Laboratories International SRL subsidiary purchasing GlaxoSmithKline's U.S. and Canadian rights to non-ophthalmic topical formulations of cold sore drug Zovirax acyclovir
Set Email Alert